O
Optomed Oyj
OMXH:OPTOMED
Optomed Oyj
OMXH:OPTOMED
Price:
2.32
EUR
-2.73%
Market Closed
Market Cap:
€49.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
FI |
|
V
|
Viet Phat Import Export Trading Investment JSC
VN:VPG
|
VN |
|
Korea Zinc Inc
KRX:010130
|
KR |
|
A
|
Alset Capital Inc
OTC:ALSCF
|
CA |
|
Post Holdings Inc
NYSE:POST
|
US |
|
Kiplin Metals Inc
F:17G1
|
CA |
|
Bio Path Holdings Inc
NASDAQ:BPTH
|
US |
|
P
|
PCC Exol SA
WSE:PCX
|
PL |
|
Aib Group PLC
F:A5G
|
IE |
|
Rossell India Ltd
NSE:ROSSELLIND
|
IN |
|
Renascor Resources Ltd
ASX:RNU
|
AU |
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
KR |
|
A
|
Australian Unity Office Fund
ASX:AOF
|
AU |
|
British Land Company PLC
LSE:BLND
|
UK |
|
Watches of Switzerland Group PLC
LSE:WOSG
|
UK |
|
Aarti Industries Ltd
NSE:AARTIIND
|
IN |
|
Turkiye Petrol Rafinerileri AS
IST:TUPRS.E
|
TR |
Multiples-Based Value
The Multiples-Based Value for Optomed Oyj (OPTOMED) under the Base Case is hidden EUR. Compared with the current market price of 2.32 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OPTOMED Multiples-Based Value
LOCKED
Multiples Across Competitors
OPTOMED Competitors Multiples
Optomed Oyj Competitors
Optomed Oyj Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
O
|
Optomed Oyj
OMXH:OPTOMED
|
49.7m EUR | 2.9 | -7.5 | -11.6 | -6.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.4B USD | 4 | 27.3 | 15.7 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.5B USD | 16 | 56.6 | 42.8 | 52.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.7B USD | 5.2 | 40 | 20.4 | 24.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
90.9B USD | 4.5 | 31.4 | 18.6 | 25 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.1B EUR | 1.8 | 20 | 11.2 | 15.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD | 7.6 | 42.8 | 23.5 | 25.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.6B USD | 10.8 | 44 | 31.2 | 34.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.2B USD | 1.6 | 15.9 | 11.5 | 13.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
